Belite Bio Inc (BLTE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BLTE Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Belite Bio Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent337.29
Cash, Cash Equivalents Other15.64
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments352.00
Other Receivables, Net, Current0.70
Notes Receivable, Current0.02
Other Current Assets139.49
Prepaid Expense And Other Assets Current0.49
Total Current Assets494.27
Equipment/Property/Plant Net0.51
Intangible Assets0.02
Deposits Assets, Noncurrent AS0.25
Tax Assets, Noncurrent20.49
Prepaid Expense, Noncurrent, Total PR4.90
Other Assets, Noncurrent260.77
Total Assets780.56
Liabilities
Accrued Liabilities, Current AC9.64
Other Liabilities, Current0.01
Total Current Liabilities9.88
Total Long-term Debt0.00
Other liabilities, Noncurrent0.43
Total Liabilities10.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock956.28
Retained Earnings / Accumulated Deficit-185.26
Accumulated Other Comprehensive Income-0.54
Other Equity-0.54
Common Stockholder's Equity770.49
Total Stockholder's Equity770.49
Liabilities & Stockholder's Equity780.56
4 historic quarters locked

Sign in to unlock the full Belite Bio Inc balance sheet history.

About Belite Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037374

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.